Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart

Similar documents
Annex 2 A. Regional profile: West Africa

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

AIDS in Africa. An Update. Basil Reekie

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

IMMUNIZATION VACCINES & EMERGENCIES

What is this document and who is it for?

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Eligibility List 2018

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Comparative Analyses of Adolescent Nutrition Indicators

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

WHO Response to the PHEIC: Zika, Microcephaly, and Guillain- Barré Syndrome Member States Briefing. February 2016

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

THE CARE WE PROMISE FACTS AND FIGURES 2017

Scaling Up Nutrition Action for Africa

Everything you ever wanted to know about Zika Virus Disease

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

IMMUNIZATION VACCINE DEVELOPMENT

מדינת ישראל. Tourist Visa Table

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

PUBLIC HEALTH UPDATE

This also applies to all travellers transiting through countries with risk of transmission of yellow fever.

Global Fund ARV Fact Sheet 1 st June, 2009

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

AFRICA. The continent of All challenges

General Description. Significance

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

ANNEX 3: Country progress indicators

TFI Proceedings, Recommendations and implications for 2005

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Financing malaria control

UNAIDS 2013 AIDS by the numbers

Global Fund Results Fact Sheet Mid-2011

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

Update from GAVI Aurelia Nguyen

IMMUNIZATION VACCINE DEVELOPMENT

JOINT TB AND HIV PROGRAMMING

ASLM Building laboratory capacity in Africa in a sustainable way

Maternal Deaths Disproportionately High in Developing Countries

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

55th DIRECTING COUNCIL

Africa s slow fertility transition

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Influenza Surveillance In the WHO African Region

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

Ouagadougou Declaration

Okwen PM 1,2, Maweu IW 1,3, Ndimbum CN 1, Evina Danielle 2 Ongolo-Zogo Pierre 2, George Nel 4, Anastase Dzudzie 4, Dike Orji 4, Mayosi Bongani 4

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

Welcome All. Western Australia Oncology Menopause Endometriosis New Mothers

Tipping the dependency

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

Impact Dashboard - October 2014

Demographic Transitions, Solidarity Networks and Inequality Among African Children: The Case of Child Survival? Vongai Kandiwa

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

Global malaria mortality between 1980 and 2010: a systematic analysis

Impact of Pathology Implementation Strategies in Sub Saharan Africa

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Overview of WHO/UNICEF Immunization Coverage Estimates

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME

Global summary of the AIDS epidemic, December 2007

Malaria. You are part of it! Healthier, fitter, safer.

CDER EDITORIAL Through this issue of the

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

Prioritizing Emergency Polio Eradication Activities

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

World Health Organization Department of Communicable Disease Surveillance and Response

Ageing and mental health resources for older persons in the African region of the World Health Organization

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

Impact Dashboard - August 2014

THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION

Chikungunya: Perspectives and Trends Global and in the Americas. Presenter: Dr. Eldonna Boisson PAHO/WHO

Expert Group Meeting on the Regional Report for the African Gender and Development Index

Global Fund Mid-2013 Results

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

SGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

Progress has been made with respect to health conditions.

The Global HIV/AIDS Epidemic, risk factors for transmission. and Global response. Training Course in Sexual and Reproductive Health Research 2014

Yellow fever Vaccine investment strategy

Certificate of Immunization

AGaRT The Advisory Group on increasing access to Radiotherapy Technology in low and middle income countries

Financing the HIV response in sub- Saharan Africa from domestic sources: moving beyond a normative approach

Transcription:

Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region Dr Zabulon Yo, & Dr Anthony Stewart

Presenta:on Outline Background informa:on on Zika Global situa:on and Zika as a Public Health Event of Interna:onal Concern Zika virus in the African Region & Regional preparedness and response

Background informa:on (1) Zika Virus Disease: transmiied through mosquito bite (especially Aedes aegyp*) Same mosquito species transmits Chikungunya, Dengue, Yellow Fever First iden:fied in 1947 in rhesus monkeys in the Zika forest of Uganda Isolated in humans in 1952 in Uganda and Tanzania Clinically mild, self-limited disease with rash, fever, conjunc:vi:s and arthralgia

Background informa:on (2) There is no specific treatment or vaccine currently available The best form of preven:on is protec:on against mosquito bites The virus is known to circulate in Africa, the Americas, Asia and the Pacific Zika Virus geographical distribu:on has steadily increased since discovery in 1947 (and especially in 2015-2016)

Predicted distribu:on of Zika virus vector, the Aedes aegyp* mosquito

Countries & territories with Zika Virus (1947-2016) Steady increase in 2015-2016

Confirmed and Suspected Cases 18000 16000 14000 12000 10000 Confirmed & suspected Zika cases reported by countries and territories in the Americas, 2015-2016 8000 6000 4000 2000 0 Cumula:ve cases as of 12 Feb: - Confirmed: 2,063 - Suspected: 118,208 -Total cases: 120,271 Epidemiological Week Venezuela United States Virgin Islands Suriname Saint Mar,n Puerto Rico Paraguay Panama Nicaragua Mexico Mar,nique Jamaica Honduras Hai, Guyana Guatemala Guadeloupe French Guiana El Salvador Ecuador Dominican Republic Curaco Costa Rica Columbia Brazil Bolivia Barbados Source: hup://ais.paho.org/phip/viz/ed_zika_epicurve.asp

Zika Outbreak as a PHEIC May-Dec 2015: Regular situa:on reports issued by PAHO and HQ indicated increase in cases of microcephaly & GBS The cluster of microcephaly cases and other neurological disorders reported in Brazil and Polynesia 8 other countries reported increase in cases of Guillain-Barré syndrome IHR CommiIee advised DG WHO that the increase in neurological complica:ons with possible associa:on with Zika virus infec:on cons:tutes a Public Health Emergency of Interna:onal Concern (PHEIC)

Columbia GBS cases increase with Zika virus

DG/WHO declared microcephaly & GBS to be a Public Health Emergency of Interna:onal Concern (PHEIC) Global Response Timelines May 2015: Incident management established in PAHO May-Dec 2015: Regular sit reps issued by PAHO and HQ on spread of Zika Virus, microcephaly, and GBS 26 Jan 2016: WHO declared grade 2 emergency and established IMS 1 Feb 2016: DG declares PHEIC 3-4 Feb 2016: Strategic plan reviewed with GOARN and IASC partners 8 Feb 2016: $2.3 m released from Con,ngency Emergency Fund Feb 2016: all Regional Offices appointed Incident Managers. 17 Feb 2016: WHO release Strategic Response Plan

WHO Strategic Response Plan (17 Feb 2016) Inves:gate and respond to microcephaly and GBS that could be linked to Zika infec:on, while increasing preven:ve measures, communica:ng risks and providing care to those affected.

Zika virus in the African region Aher 1952, Zika virus was reported in Uganda, Tanzania, CAR, Senegal, Cote d Ivoire, Various surveys indicate the existence of Zika virus infec:ons in some African countries among persons and mosquitoes e.g. Zambia: Serologic surveys in Yellow Fever found 6% Zika virus in 2013 Gabon : Zika virus reported in Aedes mosquito in 2007 ZIKV-associated disease may be underreported or misdiagnosed

Zika virus outbreak in Cape Verde Outbreak of Zika declared in October 2015 7,258 suspected and confirmed cases reported since the onset Down-ward trend since December 2015 No neurological complica:ons observed so far Control measures ins:tuted include: enhanced surveillance, lab diagnosis, case management, IVM and risk communica:on AFRO provided support to ship samples to Ins:tute Pasteur in Dakar for laboratory tes:ng and confirma:on

Zika virus Epidemic curve, Cape Verde as of week 4, 2016 2015

Zika virus Outbreak Risk Assessment & Mapping Transmission poten:al Outbreak Risk

AFRO Response to Zika virus PHEIC Communica:on to all the 47 countries through WRs providing guidance to the Ministries of Health/partners, RCs/UNCTs Incident Management System (IMS) established in the RO to coordinate the preparedness and response ac:vi:es (03/02/2016) Briefing of Ministers of Health and partners from the Central African sub-region in Libreville, 10-14 Feb 2016 On-sight trainings and provision of reagents planned to support lab confirma:on through the exis:ng Emerging Dangerous Pathogens Lab network (EDPLN) Contribu:on to the development of the Global Opera:onal Plan AFRO developed a regional preparedness and response plan

AFRO Preparedness & Response Strategy Partnerships PREPAREDNESS SURVEILLANCE RESPONSE MONITORING & RESEARCH Ø Strengthen coordina,on mechanisms for PHE response Ø Conduct risk assessment and mapping Ø Strengthen surveillance and capacity for lab tes,ng Ø Monitor for Zika virus (entomological and human) Ø Increase access and interven,ons for vector control/ personal protec,on Ø Risk communica,ons/community engagement Ø Management of cases and neurologic syndromes Ø Control spread of Aedes mosquito (IVM) Ø Provide guidance & care for pregnant women, those considering pregnancy, and families with children affected Ø Inves,gate e,ology of microcephaly, neurological syndromes and establish possible consequences of Zika virus infec,on Ø Fast-track R&D of new products (e.g. rapid diagnos,cs, vaccines, therapeu,cs). Opera,onal partners network Technical partners network Opera,onal & Technical partners Technical networks R&D partners

Priori:za:on of ac:vi:es Country Context Category 1: High risk Category 2: Medium risk Category 3: Low risk Countries Angola, Benin, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Cote d'ivoire, Equatorial Guinea, Eritrea, Ethiopia, Guinea-Bissau, Liberia, Madagascar, Mauritania, Mozambique, Nigeria, South Sudan and Togo Algeria, Botswana, Burkina Faso, Congo, DRC, Gabon, Gambia, Guinea, Kenya, Malawi, Mali, Niger, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Tanzania, Uganda and Zimbabwe Ghana, Lesotho, Mauri:us, Namibia, South Africa, Swaziland and Zambia Strengthen coordina:on mechanisms for PHE response Strengthen surveillance and capacity for lab tes:ng Engage communi:es communicate risks Monitor for Zika virus Control* transmission Inves:gate possible complica:ons associated with Zika virus* * Only in countries with ongoing infec,on

Thank you More informa,on on: hup://who.int/emergencies/zika-virus/response/en/